Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 45Gastrointestinal 14Thoracic 9Gynecologic 8Genitourinary 8Breast 8Sarcoma 7Head & Neck 5Dermatologic 5CNS 4Other hematologic neoplasm 3Lymphoid 2Other solid neoplasm 1Other 1

Conditions

Melanoma 33Carcinoma, Non-Small-Cell Lung 6Uveal Melanoma 5Skin Neoplasms 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 4Kidney Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Mycosis Fungoides 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urticaria Pigmentosa 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Pruritus 1Pancreatic Neoplasms 1

Interventions

pembrolizumab 40Nivolumab 18trametinib 13Cyclophosphamide 13dabrafenib 11Vemurafenib 10Interleukin-2 10Ipilimumab 9fludarabine 7Docetaxel 7fludarabine phosphate 6cemiplimab 6Paclitaxel 6Cisplatin 6Carboplatin 6atezolizumab 5Radiotherapy 5Drug Therapy 5Dacarbazine 5Blood Specimen Collection 5Biopsy 5poly ICLC 4binimetinib 4Therapeutics 4Psychiatric Rehabilitation 4sotigalimab 3montanide ISA 51 3encorafenib 3cobimetinib 3budigalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × Blood Specimen Collection × Dermatologic × Clear all
NCT01046487 2026-03-13

PALANGI3

Centre Oscar Lambret

Phase 1 Completed
26 enrolled
DermatologicGastrointestinalSarcoma

Uveal Melanoma, Chordoma, Carcinoma, Adenoid Cystic, Neoplasms, Desmoid Tumors, Dermatofibrosarcoma, Gastrointestinal Stromal Tumors

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting
150 enrolled
Dermatologic

Melanoma, Neoplasms

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

M.D. Anderson Cancer Center

Terminated
131 enrolled
Dermatologic

Melanoma, Neoplasms

NCT03787056 2021-07-16

ONCOPRO

Hospices Civils de Lyon

Phase NA Recruiting
410 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Ardigen

Unknown
130 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡